These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 6188898)

  • 41. Effects of ibopamine on heart performance: a radionuclide ventriculography study in patients with idiopathic dilatative cardiomyopathy.
    Gronda E; Brusoni B; Inglese E; Mangiavacchi M; Gasparini M; Ghirardi P
    Arzneimittelforschung; 1986 Feb; 36(2A):371-5. PubMed ID: 3518724
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Assessment of the cardiohemodynamic effects of ibopamine, an orally-active dopamine analogue, in the anesthetized open-chest guinea pig and the isolated guinea pig atria.
    Matsui K; Imai S
    Jpn J Pharmacol; 1986 Oct; 42(2):217-27. PubMed ID: 3795623
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of acute and chronic ibopamine administration on resting and exercise hemodynamics, plasma catecholamines and functional capacity of patients with chronic congestive heart failure.
    Dei Cas L; Metra M; Visioli O
    Am J Cardiol; 1992 Sep; 70(6):629-34. PubMed ID: 1354938
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Ibopamine in chronic congestive heart failure: hemodynamic and neurohumoral effects.
    López-Sendón J
    Am J Med; 1991 May; 90(5B):43S-49S. PubMed ID: 1675551
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Ibopamine--how should it be used?
    Bussmann WD; Wienhöfer K; Frik R
    Cardiology; 1988; 75 Suppl 1():126-37. PubMed ID: 3069210
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The diisobutyryl ester of N-methyldopamine, ibopamine: evaluation of electrophysiological properties and arrhythmogenicity studies.
    Ciampani N; Massacci C; Capestro F; Breccia Fratadocchi G; Mocchegiani R; Ruga O; Purcaro A
    Arzneimittelforschung; 1986 Feb; 36(2A):363-6. PubMed ID: 3707651
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Acute haemodynamic effects of ibopamine and dopamine on isovolumic relaxation.
    Bernardi L; Perlini S; Soffiantino F; Farilla C; Calciati A; Soldá PL; Paro M; Merlo L; Marchetti G; Finardi G
    Eur J Pharmacol; 1989 May; 164(3):415-24. PubMed ID: 2767116
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pharmacological profile of ibopamine. A summary of experiments on anaesthesized dogs.
    Marchetti GV
    Cardiology; 1990; 77 Suppl 5():22-9. PubMed ID: 1980631
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hemodynamic and neurohumoral effects of ibopamine in patients with chronic congestive heart failure.
    López-Sendón J
    Cardiology; 1990; 77 Suppl 5():9-21. PubMed ID: 1980634
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Hemodynamic effects induced by ibopamine in myocardiopathy patients].
    Dei Cas L; Cucchini F; Bolognesi R; Fappani A; Manca C; Riva S
    Cardiologia; 1982; 27(6):601-2. PubMed ID: 6234903
    [No Abstract]   [Full Text] [Related]  

  • 51. Clinical pharmacology of ibopamine.
    Itoh H
    Am J Med; 1991 May; 90(5B):36S-42S. PubMed ID: 1675550
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pharmacotherapeutic profile of ibopamine in heart failure.
    Taylor SH
    J Cardiovasc Pharmacol; 1989; 14 Suppl 8():S118-23. PubMed ID: 2483437
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Effects of short-term administration of ibopamine on hemodynamic parameters].
    Perroni GB; Longo FN; Anzà V; Girasella R; Macrì I; Urbano O
    Minerva Med; 1989 May; 80(5):461-8. PubMed ID: 2747973
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Double-blind placebo-controlled study of ibopamine and digoxin in patients with mild to moderate heart failure: results of the Dutch Ibopamine Multicenter Trial (DIMT).
    van Veldhuisen DJ; Man in 't Veld AJ; Dunselman PH; Lok DJ; Dohmen HJ; Poortermans JC; Withagen AJ; Pasteuning WH; Brouwer J; Lie KI
    J Am Coll Cardiol; 1993 Nov; 22(6):1564-73. PubMed ID: 7901256
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hemodynamic effects of intravenous butopamine in congestive heart failure.
    Thompson MJ; Huss P; Unverferth DV; Fasola A; Leier CV
    Clin Pharmacol Ther; 1980 Sep; 28(3):324-34. PubMed ID: 7408391
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Positive inotropic effects of ibopamine in patients with congestive heart failure. A multicenter investigation.
    Caponnetto S; Allegro A; Bellotti G; Cataldi A; Salvemini M; Portioli I; Prati PL; Gambelli G; Boccanelli A; Zacharo E
    Arzneimittelforschung; 1986 Feb; 36(2A):386-90. PubMed ID: 3518725
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Effects of ibopamine on the peripheral circulation of normal subjects after protracted administration].
    Musacci GF; Longhini C; Ansani L; Toselli T; Pinca L; Dell'Acqua G
    Cardiologia; 1982 Dec; 27(12):1171-5. PubMed ID: 6927475
    [No Abstract]   [Full Text] [Related]  

  • 58. Hemodynamic effects of ibopamine on the pulmonary circulation and right ventricular performance in patients with chronic obstructive pulmonary disease.
    Skwarski K; Barratt A; MacNee W
    Cardiology; 1992; 80(5-6):349-55. PubMed ID: 1451122
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of ibopamine on peripheral haemodynamics.
    Longhini C; Musacci GF; Ansani L; Toselli T; Artioli M; Bianco L; Ghirardi P
    Eur J Clin Pharmacol; 1983; 24(5):585-9. PubMed ID: 6873134
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Acute hemodynamic effects of ibopamine, captopril, and placebo in patients with severe heart failure].
    Cantarelli MJ; Carvalho AC; de Almeida DR; Azevedo JE; Smith AC; Campos Filho O; Martinez Filho EE
    Arq Bras Cardiol; 1995 Apr; 64(4):335-9. PubMed ID: 7495392
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.